Translating clinical trial data into new patterns of practice.

Purpose: The ongoing research into the intricacies of glucoregulation and the upsurge in the number of pharmacologic therapies has broadened the treatment options for type 2 diabetes. Successful translation of pharmacologic clinical trial data into new patterns of practice begins by creating the space for a new therapy through a thorough understanding of its mechanism of action.

Conclusion: This article will discuss important considerations for identifying patients who could benefit from incretin mimetic therapy, the role of the diabetes educator in building a cohesive team, and teaching strategies that support patients' self-management efforts.